Troponin News and Research

RSS

ACE inhibitors show no benefit in reducing chemotherapy-induced heart damage

Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracycline chemotherapy did not show any difference in troponin T levels, a biomarker associated with heart damage, at one month after their last chemotherapy dose compared with those who did not take an ACE inhibitor, according to a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

PROSPERITY trial reveals no negative cholesterol impact from fortified eggs

Whether you like your eggs sunny-side up, hard boiled or scrambled, many hesitate to eat them amid concerns that eggs may raise cholesterol levels and be bad for heart health.

28 Mar 2024

Long COVID's impact on cardiovascular health: what we do and do not know

Researchers review the cardiovascular effects of long COVID.

23 Jan 2024

Gene therapy shows promise for arrhythmogenic cardiomyopathy

Researchers evaluated the effectiveness of adeno-associated virus (AAV)-mediated Plakophilin 2 (PKP2) delivery in treating arrhythmogenic cardiomyopathy (ACM).

12 Dec 2023

The impact of implementing a high sensitivity assay for cardiac troponin I on long term outcomes in patients with suspected acute coronary syndrome

Researchers from the United Kingdom evaluated the use of a high-sensitivity assay to measure cardiac troponin I and its impact on myocardial infarction (MI) risk or other long-term outcomes such as death at five years in individuals with suspected acute coronary syndrome.

30 Nov 2023

Lasting heart concerns in kids post-MIS-C: Study urges ongoing cardiac checks

Researchers evaluated the long-term cardiovascular effects in children after treatment for MIS-C, a condition linked to COVID-19. They found that regardless of initial heart injury, most children displayed persistent cardiac abnormalities, underscoring the importance of ongoing cardiac monitoring post-recovery.

16 Nov 2023

CVD-21: A novel instrument for predicting and monitoring cardiovascular disease

Researchers at Uppsala University have developed an instrument that makes it possible to measure 21 biomarkers for cardiovascular disease simultaneously with great precision by means of a simple blood test.

15 Nov 2023

Expert consensus on the classification of acute atherothrombotic myocardial infarction by stage of tissue injury severity

A document published in the Canadian Journal of Cardiology outlines the Canadian Cardiovascular Society's classification of acute MI.

1 Nov 2023

Warm-ups may improve muscle performance by exploiting temperature sensitivity

Everybody knows the importance of warming up your muscles before a workout. But what is actually going on when we warm our muscles up, and are all muscles the same? You might be surprised to find out that the science behind this routine activity hasn't always been clear.

24 Oct 2023

Examining the cardiac pathology in fatal cases of yellow fever

The characteristics of yellow fever (YF)-related myocardial damage.

28 Sep 2023

ARAMIS trial finds no benefit of anakinra in acute myocarditis

The largest randomized controlled trial of patients with acute myocarditis has found that anakinra is safe but does not reduce complications. The late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Colchicine does not reduce perioperative AF or MINS in major non-cardiac thoracic surgery

Colchicine does not significantly reduce perioperative atrial fibrillation (AF) or myocardial injury after non-cardiac surgery (MINS) in patients undergoing major non-cardiac thoracic surgery, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

25 Aug 2023

Simple blood test may predict risk of progressive heart and kidney disease in people with diabetic kidney disease

A simple blood test may predict the risk of progressive heart and kidney disease in people with Type 2 diabetes and kidney disease, according to new research published today in the American Heart Association's flagship journal Circulation.

21 Aug 2023

High troponin levels associated with increased risk of death from any cause

A high level of troponin-;a protein normally used to exclude the possibility of a heart attack in patients with chest pain-;may signal a heightened risk of death from any cause within the next couple of years, even in the absence of known or suspected cardiovascular disease, suggests research published online in the journal Heart.

7 Aug 2023

Study suggests global longitudinal strain is a powerful independent predictor of adverse outcomes in patients with heart failure and diabetes

Researchers determine the prognostic significance of GLS by cardiac magnetic resonance and identify plasma biomarkers linked with fibrosis and inflammation.

31 Jul 2023

Researchers identify how enzymes can help prevent heart damage in chemotherapy patients

Researchers at the University of Illinois Chicago have identified a process by which enzymes can help prevent heart damage in chemotherapy patients.

20 Jul 2023

Improved diagnosis of occlusion myocardial infarction using novel machine learning tools

Machine learning models were developed to diagnose heart attacks in patients with no ST-elevation on their initial electrocardiogram, outperforming clinicians and improving accuracy. The models' risk score enhanced diagnostic accuracy and reclassified chest pain patients, providing mechanistic links to heart injury.

6 Jul 2023

Cardiac MRI is a safe and valuable tool to help evaluate patients with acute chest pain

An estimated 3 million patients visit emergency departments each year with acute chest pain and mildly elevated troponin levels.

20 Jun 2023

One-third of adults in the U.S. with Type 2 diabetes may have symptomless cardiovascular disease

1 in 3 adults with Type 2 diabetes may have undetected cardiovascular disease. Elevated levels of two protein biomarkers that indicate heart damage were associated with undetected or symptomless cardiovascular disease in adults with Type 2 diabetes compared to those without Type 2 diabetes, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

31 May 2023

Can machine learning improve myocardial infarction diagnosis?

Researchers discuss a novel clinical decision support system based on machine learning models to predict an individual’s probability of myocardial infarction.

15 May 2023